Dicarboxylic acids are prominent features of several diseases,
Introduction
Dicarboxylic acids are the product of omega-oxidation in the microsomes. Only 5-10% of FFA are metabolized by this pathway in ketotic rats (1) . However, dicarboxylic acids have recently been shown to be a prominent feature of several diseases, including Reye's syndrome (2) (3) (4) , neonatal adrenoleukodystrophy (5), Zellweger's syndrome (5) , and defects of fatty acid metabolism (6, 7) . In Reye's syndrome, dicarboxylic acids make up as much as 55% of the total serum FFA (4) .
The hallmark ofReye's syndrome is a transient generalized impairment of mitochondrial enzymes and swelling and distortion of mitochondrial ultrastructure (8) . Several toxins, including aspirin, have been suggested to predispose children to this illness (9) . Serum from patients with Reye's syndrome impairs ATP formation and induces swelling and distortion of isolated mitochondria (10) . These effects correlate directly with the concentration ofdicarboxylic acids in the serum samples (10) . Studies with isolated mitochondria have demonstrated that dicarboxylic acids, particularly long-chain dicarboxylic acids, at concentrations comparable to those in plasma of patients with Reye's syndrome, profoundly inhibit the enzymes of the terminal respiratory pathway (1 1), inhibit ATP formation (10) , and induce an irreversible expansion of mitochondria characteristic of an uncoupler of oxidative phosphorylation (12) . Dicarboxylic acids thus may contribute to the mitochondrial dysfunction that is central to Reye's syndrome (10) . The regulation of dicarboxylic acid metabolism may therefore be important in Reye's syndrome and other diseases in which dicarboxylic acid formation is prominent.
The binding of monocarboxylic fatty acids to albumin and the intracellular fatty acid-binding proteins modulates the transport and metabolism ofthese fatty acids (13, 14) . Binding of potentially toxic ligands to albumin protects against the toxic effects of the ligands, as toxicity is proportionate to the concentration of unbound ligand (13, 15, 16) . We undertook this study to determine the affinity and capacity ofalbumin for dicarboxylic acids.
Methods
Monocarboxylic and dicarboxylic acids. Unlabeled monocarboxylic and dicarboxylic acids were purchased from Sigma Chemical Co. (St. Louis, MO), Applied Science (Warrenville, IL), and Foxboro Analabs (North Haven, CT). The purity of the unlabeled acids was assessed by gas-liquid chromatography and was found to Albumin. Essentially fatty acid-free (< 0.005%) crystalline BSA was from Sigma Chemical Co. and further purified as described by Spector, John, and Fletcher ( 18) . The monocarboxylic fatty acid content of the purified albumin was determined by gas-liquid chromatography (4) and found to have < 0.02 mol fatty acid/mol of albumin.
Equilibrium dialysis. Binding ofdicarboxylic acids to defatted BSA was determined using equilibrium dialysis as described by Ashbrook, Spector, and Fletcher (19) . Dialysis chambers and membranes were from Bel-Art Products (Pequannok, NJ). The chamber contains two l-ml compartments separated by a dialysis membrane that is impermeable to compounds with a molecular weight > 6,000; albumin does not cross the dialysis membrane (19 Equilibrium constants for saturated straight-chain dicarboxylic acids. Binding was assessed in the presence of 0.050 mM albumin for all of the dicarboxylic acids except octadecanedioic acid, which was incubated with 0.010 mM albumin. * Indicates the mol ratio of fatty acid to albumin at saturation as observed experimentally.
The binding of octadecanedioic acid is hexadecanedioic acid (Fig. 2) . Octadecane in a 3.8:1 molar ratio ( Figure 2 . Binding of dicarboxylic acids to defattec was assessed as described in Fig. 1 with the except ing of octadecanedioic acid was assessed with 0.01
Octadecanedioic acid (C18), tetradecanedioic acid dioic acid (C12), and decanedioic acid (CO0).
; similar to that of experimentally for dodecanedioic and decanedioic acids is 0.8 lioic acid is bound and 0.7 mol/mol of albumin (Fig. 2 , Table I (Fig.   3 ). The pH ofthe buffer has no significant effect on the K, for C14 hexadecanedioic acid but the Kd decreases at the more acidic 00 s pH. The dissociation constant for dodecanedioic acid also decreases at pH 6.8 (Table I) .
Competition with monocarboxylic fatty acids for binding. We examined the effect of the monocarboxylic acid, oleic acid (C18.1) on the binding of dicarboxylic acids using 0.1, 0.3, and 'do .o...... 0.5 mM C18.1 (Fig. 4, Table II ). C18.1 competes with hexade-C10 canedioic acid for binding; as a result, the apparent dissociation constant of the dicarboxylic acid increases 15-35-fold (from 1.2±1.4 to 41.0±7.3 ,uM, Table II ). When the monocar-00 0 boxylic acid concentration is increased to 0.5 mM (a 10:1 C18.1/albumin ratio), all but 0.70 mol of hexadecanedioic acid is displaced (Fig. 4 III). In the absence of any competition, between 0.8 and 0.9 mol are bound per mol of albumin. When 2-3 mol of C18.1 are bound to albumin (0.10-0.15 mM C18.), the affinity for dodecanedioic acid is reduced almost fivefold (Table II) , but there is no significant effect on the maximal binding capacity (Tables  II and III) . When 4-5 mol of C18.1 are bound to albumin (0.3-0.5 mM C18.1) the affinity is reduced ninefold (Table II) -0.1 mM OLEIC ACID FREE HEXADECANEDIOIC ACID (uM) .00 and the experimentally observed binding capacity of dodecanedioic acid is reduced by more than half (Table III) . The medium-chain length monocarboxylic acid, octanoic acid (C8.0) has a more profound effect on the binding of dodecanedioic acid (Table III) . When 0.5 mol of C8.0 per mol of albumin are bound, only 0.1-0.2 mol of dodecanedioic acid is bound and when 1 mol of C8.0 per mol of albumin is bound, the binding of dodecanedioic acid is further inhibited.
Discussion
Our results indicate that dicarboxylic acids bind to albumin with lower affinity than monocarboxylic acids of the same chain length. There is a single low-affinity site for dodecanedioic and decanedioic acid. There is a single higher affinity site for the longer chain dicarboxylic acids (C18-C14) with between one and four additional low-affinity sites, depending on the chain length of the dicarboxylic acid. The affinity of longchain dicarboxylic acids for albumin is 100-1,000-fold less than that of long-chain monocarboxylic fatty acids and is more comparable to the affinity of many drugs for albumin (25) . The molar ratio of bound dicarboxylic acid to albumin observed is also significantly less than that reported for monocar- Competition of oleic acid with dicarboxylic acids for binding. * Indicates the mol ratio of fatty acid to albumin, as observed experimentally. The pH of the buffer exerts only a modest effect on the binding of dicarboxylic acids. The pK of each of the carboxyl groups for octanedioic acid is 4.52 (26) . The dissociation constants for longer chain dicarboxylic acids are probably close to this value. Thus, the dicarboxylic acids are > 99% deprotonated in the physiologic pH range we examined. The modest shift in binding at pH 6.8 may be due to a change in amino acid charge at one or more binding sites which facilitates binding of dicarboxylic acids.
As might be expected from a comparison of the dissociation constants of moncarboxylic and dicarboxylic acids, monocarboxylic acids competitively inhibit dicarboxylic acid binding. However, the competition studies demonstrate that at high enough concentrations, dicarboxylic acid can bind and displace some C18.I. The albumin molecule is composed of three nonidentical cylindrical domains (13) , each of which has a narrow hydrophobic channel able to accomodate only one or two hydrocarbon chains. The ends of each domain form nonidentical subdomains containing positively charged amino acid side chains. Recent studies indicate that medium-chain monocarboxylic fatty acids bind almost exclusively via hydrophobic interactions, whereas the binding oflong-chain monocarboxylic acids is dependent on both electrostatic and hydrophobic interac- Competition of dodecanedioic with the monocarboxylic acids octanoic, and oleic. Binding was assessed as described in Fig. 5 . (27) . Three (19) , only 1 mol of medium-chain dicarboxylic acid is bound per mol of albumin.
Our observations suggest that the single high-affinity site for long-chain dicarboxylic acids may be one ofthe high-affinity sites for monocarboxylic fatty acids. As shown in Table II , when the high-affinity monocarboxylic acid binding sites are largely occupied (0.1 mM C18.1), there appears to be only a single class of low-affinity sites for dicarboxylic acids, having a dissociation constant similar to that of the low-affinity sites in the absence of any competition. On the other hand, the lowaffinity sites for long-and medium-chain length dicarboxylic acids are distinct from the primary binding sites for long-chain monocarboxylic acids, as when these latter sites are occupied by monocarboxylic acids, all the low-affinity sites for hexadecanedioic and dodecanedioic acids are still available (Tables II   and III) ; the dicarboxylic acids are only displaced when the bound C18.1 exceeds 3 mol/mol of albumin. Moreover, C8.0 is more effective than C18.1 (Table III) in inhibiting the binding at the low-affinity site. We infer from these considerations that some or all of the low-affinity sites for medium-and longchain dicarboxylic acids are in the subdomains ofalbumin that bind medium-chain monocarboxylic fatty acids and drugs.
These studies confirm our hypothesis that dicarboxylic acids are not as tightly bound to albumin as monocarboxylic fatty acids (9) , and suggest that in Reye's syndrome, in which the fatty acid/albumin ratio approaches or exceeds 4:1 (4, 28), substantial concentrations of dicarboxylic acids may be free. Long-chain dicarboxylic acids are readily displaced from the higher affinity binding site. Binding to the lower affinity sites is probably also significantly impaired in patients with Reye's syndrome. The concentration of dicarboxylic acids in those patients is often as high as 0.5 mM in comatose patients, with the majority of the dicarboxylic acids being long chain (C14-C18) (4). In our experiments, when the binding of 0.5 mM hexadecanedioic acid was assessed in the presence ofnear saturating concentrations of C18.1, only 16% of hexadecanedioic acid was bound (Fig. 4) . Moreover, Goodman and others (29, 25) 
